KOMISJA NADZORU FINANSOWEGO | ||||||||||||
Raport bieżący nr | 17 | / | 2021 | |||||||||
Data sporządzenia: | 2021-10-04 | |||||||||||
Skrócona nazwa emitenta | ||||||||||||
MILESTONE MEDICAL | ||||||||||||
Temat | ||||||||||||
Approval of the Company as Vendor to Supply CompuFlo Epidural and CathCheck Verification System Across Florida’s Memorial Heathcare System | ||||||||||||
Podstawa prawna | ||||||||||||
Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
Treść raportu: | ||||||||||||
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that Memorial Regional Hospital in Hollywood, Florida., has begun the use of the CompuFlo Epidural Instrument. Memorial Regional Hospital is one of the largest hospitals in Florida. Additionally, the Company has received approval to eventually supply the CompuFlo Epidural and CathCheck Verification System disposables across Memorial Healthcare System network of hospitals, which also includes Joe DiMaggio Children’s Hospital, Memorial Regional Hospital South, Memorial Hospital West, Memorial Hospital Miramar and Memorial Hospital Pembroke. The Board of Directors of the Company is very pleased to receive the approval for use of our CompuFlo Epidural and CathCheck Verification System disposables within Memorial Regional Hospital. This approval follows extensive due diligence of the instrument within the hospital system and new sales force expansion initiatives. The clinical and safety benefits of the CompuFlo Epidural and CathCheck Verification Systems are backed by extensive published clinical data by the Company demonstrating significant reductions in epidural punctures, as well as complication rates, and contribute to a significant savings of time on the part of anesthesiologists. In the opinion of the Board of Directors of the Company the CompuFlo Epidural Instrument has the potential to reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck Verification System technology has the potential to transform the monitoring of catheter placement following an epidural procedure by confirming the placement of a catheter within two minutes, versus the 20 to 40 minutes using conventional methods. |
MESSAGE (ENGLISH VERSION) |
MILESTONE MEDICAL INC | ||||||||||||||||
(pełna nazwa emitenta) | ||||||||||||||||
MILESTONE MEDICAL | ||||||||||||||||
(skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
NJ 07039 | . | |||||||||||||||
(kod pocztowy) | (miejscowość) | |||||||||||||||
South Orange Avenue Livingston | 220 | |||||||||||||||
(ulica) | (numer) | |||||||||||||||
+11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
(telefon) | (fax) | |||||||||||||||
(e-mail) | (www) | |||||||||||||||
27-5484393 | ||||||||||||||||
(NIP) | (REGON) |
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
2021-10-04 | Keisha Harcum | Controller | Keisha Harcum |